Bernal, F <br/><br/>
Regulation of matrix metalloproteinases and their inhibitors by interferon-beta: a longitudinal study in multiple sclerosis patients.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  Jun 2009 
 - 721-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1352-4585 
<br/><br/><label>Standard No.: </label>10.1177/1352458509102920  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Female<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>In Vitro Techniques<br/>Interferon-beta--therapeutic use<br/>Leukocytes--drug effects<br/>Longitudinal Studies<br/>Male<br/>Matrix Metalloproteinase 14--genetics<br/>Matrix Metalloproteinase 8--genetics<br/>Matrix Metalloproteinase 9--genetics<br/>Matrix Metalloproteinases--genetics<br/>Matrix Metalloproteinases, Secreted--genetics<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>RNA, Messenger--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Tissue Inhibitor of Metalloproteinase-1--genetics<br/>Tissue Inhibitor of Metalloproteinase-2--genetics